Showing results (71-80 of 107) with videos related to
Sort By:
Pageof 11
International Journal of Urology : Official Journal of the Japanese Urological Association|March 26, 2013
Impact of lower urinary tract symptoms on prostate cancer risk among Japanese men with prostate-specific antigen <10 ng/mL and non-suspicious digital rectal examinationMasaya Ito, Hitoshi Masuda, Satoru Kawakami, et al.Urologia Internationalis|August 29, 2019
Incidence and Predictors of Deep Vein Thrombosis in Patients with Elevated Serum D-Dimer Prior to Surgery for Urologic MalignancyRyo Fujiwara, Noboru Numao, Yudai Ishikawa, et al.Urology|July 25, 2008
Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patientsYasuhisa Fujii, Yoshinobu Komai, Kazutaka Saito, et al.BJU International|April 24, 2012
Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatinKazutaka Saito, Shinji Urakami, Yoshinobu Komai, et al.Clinical Genitourinary Cancer|July 9, 2020
Cisplatin, Gemcitabine, and Paclitaxel as a Salvage Second-Line Therapy for Metastatic Germ-Cell CancerMotohiro Fujiwara, Tatsuro Hayashi, Hayato Takeda, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|June 15, 2012
Performance of prostate-specific antigen mass in estimation of prostate volume in Japanese men with benign prostate hyperplasiaHitoshi Masuda, Satoru Kawakami, Mizuaki Sakura, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|December 5, 2008
History of malignancy is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogramSatoru Kawakami, Fumitaka Koga, Yasuhisa Fujii, et al.Urology|February 7, 2007
Muscle-invasive urothelial carcinoma of the bladderS Bruce Malkowicz, Hendrik van Poppel, Gerald Mickisch, et al.Urology|February 15, 2011
Tumor size is a potential predictor of response to tyrosine kinase inhibitors in renal cell cancerTakeshi Yuasa, Shinji Urakami, Shinya Yamamoto, et al.International Journal of Cancer|March 10, 2011
Antitumor effect of sunitinib against skeletal metastatic renal cell carcinoma through inhibition of osteoclast functionShinya Maita, Takeshi Yuasa, Norihiko Tsuchiya, et al.Pageof 11